Advertisement
Screener

IDEXX LABORATORIES INC /DE (IDXX) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements

2.8 / 5 stars · 68/120 Roast Me

IDEXX LABORATORIES INC /DE Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements

IDEXX LABORATORIES INC /DE (IDXX) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 358.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Notes

us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-08-04

  • IDEXX LABORATORIES INC /DE incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-06-30 was 358.00K shares, a 38.38% decline year-over-year.
  • IDEXX LABORATORIES INC /DE incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2026-03-31 was 514.00K shares, a 14.76% decline year-over-year.
  • IDEXX LABORATORIES INC /DE incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-09-30 was 579.00K shares, a 23.01% decline year-over-year.
  • IDEXX LABORATORIES INC /DE incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-06-30 was 581.00K shares, a 23.85% decline year-over-year.
  • IDEXX LABORATORIES INC /DE incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2025 was 598.00K shares, a 23.23% decline from fiscal 2024.
  • IDEXX LABORATORIES INC /DE incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2024 was 779.00K shares, a 14.58% decline from fiscal 2023.
  • IDEXX LABORATORIES INC /DE incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2023 was 912.00K shares, a 6.65% decline from fiscal 2022.
  • IDEXX LABORATORIES INC /DE incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 977.00K shares, a 28.79% decline from fiscal 2021.
Period endIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month as first filedIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 monthIncremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month as first filed
2026-06-30358.00K shares
10-Q · filed 2026-08-04
443.00K shares
10-Q · filed 2026-08-04
2026-03-31514.00K shares
10-Q · filed 2026-05-05
2025-12-31598.00K shares
10-K · filed 2026-02-20
2025-09-30579.00K shares
10-Q · filed 2025-11-03
602.00K shares
10-Q · filed 2025-11-03
2025-06-30581.00K shares
10-Q · filed 2026-08-04
601.00K shares
10-Q · filed 2026-08-04
2025-03-31603.00K shares
10-Q · filed 2026-05-05
2024-12-31779.00K shares
10-K · filed 2026-02-20
2024-09-30752.00K shares
10-Q · filed 2025-11-03
803.00K shares
10-Q · filed 2025-11-03
2024-06-30763.00K shares
10-Q · filed 2025-08-04
821.00K shares
10-Q · filed 2025-08-04
2024-03-31861.00K shares
10-Q · filed 2025-05-01
2023-12-31912.00K shares
10-K · filed 2026-02-20
2023-09-30896.00K shares
10-Q · filed 2024-10-31
932.00K shares
10-Q · filed 2024-10-31
2023-06-30897.00K shares
10-Q · filed 2024-08-06
941.00K shares
10-Q · filed 2024-08-06
2023-03-31967.00K shares
10-Q · filed 2024-05-01
2022-12-31977.00K shares
10-K · filed 2025-02-21
2022-09-30866.00K shares
10-Q · filed 2023-11-01
1.00M shares
10-Q · filed 2023-11-01
2022-06-30936.00K shares
10-Q · filed 2023-08-01
1.06M shares
10-Q · filed 2023-08-01
2022-03-311.15M shares
10-Q · filed 2023-05-02
2021-12-311.37M shares
10-K · filed 2024-02-22
2021-09-301.39M shares
10-Q · filed 2022-11-01
1.39M shares
10-Q · filed 2022-11-01
2021-06-301.33M shares
10-Q · filed 2022-08-02
1.37M shares
10-Q · filed 2022-08-02
2021-03-311.39M shares
10-Q · filed 2022-05-04
2020-12-311.38M shares
10-K · filed 2023-02-16
2020-09-301.38M shares
10-Q · filed 2021-11-02
1.34M shares
10-Q · filed 2021-11-02
2020-06-301.27M shares
10-Q · filed 2021-07-30
1.29M shares
10-Q · filed 2021-07-30
2020-03-311.28M shares
10-Q · filed 2021-05-04
2019-12-311.43M shares
10-K · filed 2022-02-16
2019-09-301.47M shares
10-Q · filed 2020-10-29
1.43M shares
10-Q · filed 2020-10-29
2019-06-301.40M shares
10-Q · filed 2020-07-31
1.38M shares
10-Q · filed 2020-07-31
2019-03-311.34M shares
10-Q · filed 2020-04-30
2018-12-311.61M shares
10-K · filed 2021-02-12
2018-09-301.70M shares
10-Q · filed 2019-10-31
1.66M shares
10-Q · filed 2019-10-31
2018-06-301.59M shares
10-Q · filed 2019-08-01
1.62M shares
10-Q · filed 2019-08-01
2018-03-311.61M shares
10-Q · filed 2019-05-01
2017-12-311.80M shares
10-K · filed 2020-02-14
2017-09-301.72M shares
10-Q · filed 2018-11-01
1.85M shares
10-Q · filed 2018-11-01
2017-06-301.87M shares
10-Q · filed 2018-08-01
1.90M shares
10-Q · filed 2018-08-01
2017-03-311.88M shares
10-Q · filed 2018-05-04
2016-12-311.15M shares
10-K · filed 2019-02-15
2016-09-301.24M shares
10-Q · filed 2017-10-31
1.08M shares
10-Q · filed 2017-10-31
2016-06-30993.00K shares
10-Q · filed 2017-08-01
984.00K shares
10-Q · filed 2017-08-01
2016-03-31914.00K shares
10-Q · filed 2017-04-28
2015-12-311.05M shares
10-K · filed 2018-02-16
2015-09-30953.00K shares
10-Q · filed 2016-11-01
1.07M shares
10-Q · filed 2016-11-01
2015-06-30922.00K shares
10-Q · filed 2016-08-02
1.10M shares
10-Q · filed 2016-08-02
2015-03-311.24M shares
10-Q · filed 2016-04-29
621.00K shares
10-Q · filed 2015-04-28
2014-12-311.41M shares
10-K · filed 2017-02-17
704.00K shares
10-K · filed 2015-02-17
2014-09-301.31M shares
10-Q · filed 2015-10-28
655.00K shares
10-Q · filed 2014-10-24
1.40M shares
10-Q · filed 2015-10-28
701.00K shares
10-Q · filed 2014-10-24
2014-06-301.34M shares
10-Q · filed 2015-07-30
670.00K shares
10-Q · filed 2014-07-25
1.42M shares
10-Q · filed 2015-07-30
711.00K shares
10-Q · filed 2014-07-25
2014-03-31721.00K shares
10-Q · filed 2015-04-28
2013-12-311.65M shares
10-K · filed 2016-02-17
826.00K shares
10-K · filed 2014-02-18
2013-09-30792.00K shares
10-Q · filed 2014-10-24
829.00K shares
10-Q · filed 2014-10-24
2013-06-30716.00K shares
10-Q · filed 2014-07-25
830.00K shares
10-Q · filed 2014-07-25
2013-03-31902.00K shares
10-Q · filed 2014-04-25
2012-12-311.17M shares
10-K · filed 2015-02-17
2012-09-301.15M shares
10-Q · filed 2013-10-22
1.20M shares
10-Q · filed 2013-10-22
2012-06-301.13M shares
10-Q · filed 2013-07-23
1.20M shares
10-Q · filed 2013-07-23
2012-03-311.23M shares
10-Q · filed 2013-04-23
2011-12-311.42M shares
10-K · filed 2014-02-18
2011-09-301.31M shares
10-Q · filed 2012-10-19
1.50M shares
10-Q · filed 2012-10-19
2011-06-301.45M shares
10-Q · filed 2012-07-20
1.57M shares
10-Q · filed 2012-07-20
2011-03-311.63M shares
10-Q · filed 2012-04-20
2010-12-311.85M shares
10-K · filed 2013-02-19
2010-09-301.66M shares
10-Q · filed 2011-10-21
1.89M shares
10-Q · filed 2011-10-21
2010-06-301.90M shares
10-Q · filed 2011-07-22
1.99M shares
10-Q · filed 2011-07-22
2009-12-311.87M shares
10-K · filed 2012-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lantheus Holdings, Inc. (LNTH)United States$6.510B26.31
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10